Semaglutide 5mg-VLS
Semaglutide 5mg-VLS - Image 2

Semaglutide 5mg-VLS

£ 95

Retrutide Research Material Disclaimer Non-Therapeutic Use

Function: GLP-1 receptor agonist formulation designed to support laboratory investigation into appetite regulation, metabolic signaling, and satiety-response pathways.

Focus: Used in controlled research examining semaglutide’s activity on GLP-1 receptors, its effects on satiety hormones, glucose modulation, and weight-management mechanisms.

Status: Research-grade compound intended solely for laboratory, scientific, and educational use. Not approved for human consumption, therapeutic administration, or clinical application.

Category: Brand:

Description

The VLS Semaglutide 5mg Weight Management Pen is a modern GLP-1 receptor agonist designed to help regulate appetite, improve satiety, and support long-term fat reduction. Developed by VLS Pharmaceuticals, this formulation mimics the body’s natural satiety hormones, aiding in control of cravings and metabolic balance.
The pen features an easy, precise dosing system suitable for structured weight-management regimens or research environments evaluating appetite-regulation pathways.

Key Features & Benefits

  • Helps reduce appetite and daily food cravings
  • Supports improved satiety and calorie control
  • May contribute to steady, sustainable fat loss
  • Assists in maintaining balanced blood sugar levels
  • Weekly dosing for convenience and consistency
  • Pre-filled pen allows accurate, controlled delivery

Dosing & Handling

Typical starting dose: 0.25mg per week, gradually increasing toward 1–1.25mg based on tolerance and research requirements.

Pen dose increments available:

  • 0.25mg
  • 0.5mg
  • 0.75mg
  • 1mg
  • 1.25mg

Injection is administered subcutaneously, typically in the abdomen or thigh.
Store under refrigeration and dispose of all used needles safely.

Shipping & Delivery

  • Discreet packaging
  • Fast UK delivery: 1–3 business days
  • Worldwide shipping: Europe & USA supported

Related products